Start Date
November 30, 2016
Primary Completion Date
April 4, 2017
Study Completion Date
April 4, 2017
Implantable Cardioverter Defibrillator (ICD)
Patients will receive an Implantable Cardioverter Defibrillator (ICD), with the leads implanted in either the apex or the septum as the first location. After defibrillation threshold is determined, the leads position will be changed to the second location and DFT will be determined again.
OhioHealth Grant Medical Center, Columbus
Lead Sponsor
Collaborators (1)
Abbott Medical Devices
INDUSTRY
OhioHealth
OTHER